Whole genome sequencing based characterization of extensively drug-resistant mycobacterium tuberculosis isolates from pakistan

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Ali, Asho ^a   Hasan, Zahra ^a   McNerney, Ruth ^b   Mallard, Kim ^b   Hill Cawthorne, Grant ^c,d   Coll, Francesc ^b   Nair, Mridul ^c   Pain, Arnab ^c   Clark, Taane G ^b   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBOSOME RNA; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT; BACTERIAL PROTEIN; CATALASE; EMBB PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GLYCOSYLTRANSFERASE; INHA PROTEIN, MYCOBACTERIUM; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; EMBB GENE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FUSION GENE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC PROCEDURES; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; GIDB GENE; GYRA GENE; GYRB GENE; HUMAN; INHA GENE; KATG GENE; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYR AHPC FUSION GENE; PAKISTAN; PNCA GENE; RPOB GENE; RPSL GENE; RRS GENE; SINGLE NUCLEOTIDE POLYMORPHISM; WHOLE GENOME SEQUENCING; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; GENOME, BACTERIAL; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PENTOSYLTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84923923442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117771     Document Type: Article

References (69)

1. WHO (2014) Global Tuberculosis Report. Geneva: World Health Organization. Available: http:// wwwwhoint/tb/publications/global-report/en/. p. doi: 10.1016/j.jpba.2014.12.039 PMID: 25637818
2. Ayaz A, Hasan Z, Jafri S, Inayat R, Mangi R, et al. (2013) Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes. Int J Infect Dis 16: e303-309.
3. Hasan R, Jabeen K, Ali A, Rafiq Y, Laiq R, et al. (2010) Extensively drug-resistant tuberculosis, Pakistan. Emerg Infect Dis 16: 1473-1475. doi: 10.3201/eid1609.100280 PMID: 20735937
4. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, et al. (2013) Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1: CD009593. doi: 10.1002/14651858.CD009593.pub2 PMID: 23440842
5. Hillemann D, Rusch-Gerdes S, Richter E (2009) Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 47: 1767-1772. doi: 10.1128/JCM.00081-09 PMID: 19386845
6. Supply P, Warren RM, Banuls AL, Lesjean S, Van Der Spuy GD, et al. (2003) Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol Microbiol 47: 529-538. PMID: 12519202
7. Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM (2004) Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci U S A 101: 4871-4876. PMID: 15041743
8. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, et al. (2009) Tuberculosis drug resistance mutation database. PLoS Med 6: e2. doi: 10.1371/journal.pmed.1000002 PMID: 19209951
9. Borrell S, Espanol M, Orcau A, Tudo G, March F, et al. (2009) Factors associated with differences between conventional contact tracing and molecular epidemiology in study of tuberculosis transmission and analysis in the city of Barcelona, Spain. J Clin Microbiol 47: 198-204. doi: 10.1128/JCM.00507-08 PMID: 19020067
10. Borrell S, Gagneux S (2011) Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 17: 815-820. doi: 10.1111/j.1469-0691.2011.03556.x PMID: 21682802
11. Coll F, McNerney R, Guerra-Assuncao JA, Glynn JR, Perdigao J, et al. (2014) A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun 5: 4812. doi: 10.1038/ ncomms5812 PMID: 25176035
12. Ford C, Yusim K, Ioerger T, Feng S, Chase M, et al. (2012) Mycobacterium tuberculosis-heterogeneity revealed through whole genome sequencing. Tuberculosis (Edinb) 92: 194-201. doi: 10.1016/j. tube.2011.11.003 PMID: 22218163
13. Walker TM, Ip CL, Harrell RH, Evans JT, Kapatai G, et al. (2012) Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13: 137-146. doi: 10.1016/S1473-3099(12)70277-3 PMID: 23158499
14. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol 8: 260-271. doi: 10.1038/nrmicro2319 PMID: 20208551
15. Gagneux S (2009) Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 15 Suppl 1: 66-68. doi: 10.1111/j.1469-0691.2008.02685.x PMID: 19220360
16. Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, et al. (2006) The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312: 1944-1946. PMID: 16809538
17. Mariam DH, Mengistu Y, Hoffner SE, Andersson DI (2004) Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 48: 1289-1294. PMID: 15047531
18. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, et al. (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35: 907-914. PMID: 9157152
19. Coll F, Mallard K, Preston MD, Bentley S, Parkhill J, et al. (2012) SpolPred: rapid and accurate prediction of Mycobacterium tuberculosis spoligotypes from short genomic sequences. Bioinformatics 28: 2991-2993. doi: 10.1093/bioinformatics/bts544 PMID: 23014632
20. Koneman EW AS, Dowell VR, Sommers HM. (1983) Color Atlas and Text book of Diagnostic microbiology; 1983. Publisher; JB Lippincott Company, Philadelphia. PMID: 25121320
21. Woods GL B-EB, Desmond EP, Hall GS, Heifets L, Pfyffer GE, et al. (2003) Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes: approved standard Wayne, PA: NCCLS; 2003. Document No M24-A.
22. Honore-Bouakline S, Vincensini JP, Giacuzzo V, Lagrange PH, Herrmann JL (2003) Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol 41: 2323-2329. PMID: 12791844
23. Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, et al. (2009) BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 6: 677-681. doi: 10.1038/nmeth. 1363 PMID: 19668202
24. Rausch T, Zichner T, Schlattl A, Stutz AM, Benes V, et al. (2012) DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28: i333-i339. doi: 10.1093/ bioinformatics/bts378 PMID: 22962449
25. Wang J, Mullighan CG, Easton J, Roberts S, Heatley SL, et al. (2011) CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods 8: 652-654. doi: 10.1038/nmeth. 1628 PMID: 21666668
26. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z (2009) Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25: 2865-2871. doi: 10.1093/bioinformatics/btp394 PMID: 19561018
27. Coll F, Preston M, Guerra-Assuncao JA, Hill-Cawthorn G, Harris D, et al. PolyTB: a genomic variation map for Mycobacterium tuberculosis. Tuberculosis (Edinb) 94: 346-354. doi: 10.1016/j.tube.2014.02. 005 PMID: 24637013
28. Stamatakis A (2014) RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30: 1312-1313. doi: 10.1093/bioinformatics/btu033 PMID: 24451623
29. Huson DH, Richter DC, Rausch C, Dezulian T, Franz M, et al. (2007) Dendroscope: An interactive viewer for large phylogenetic trees. BMC Bioinformatics 8: 460. PMID: 18034891
30. Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, et al. (2008) Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis 8: 171. doi: 10.1186/1471-2334-8-171 PMID: 19108722
31. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, et al. (1997) Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 94: 9869-9874. PMID: 9275218
32. Huson DH, Scornavacca C (2012) Dendroscope 3: an interactive tool for rooted phylogenetic trees and networks. Syst Biol 61: 1061-1067. doi: 10.1093/sysbio/sys062 PMID: 22780991
33. Brandis G, Hughes D (2013) Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J Antimicrob Chemother 68: 2493-2497. doi: 10.1093/jac/dkt224 PMID: 23759506
34. Jagielski T, Bakula Z, Roeske K, Kaminski M, Napiorkowska A, et al. (2014) Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates. J Antimicrob Chemother 69: 2369-2375. doi: 10.1093/jac/dku161 PMID: 24855126
35. Ajbani K, Rodrigues C, Shenai S, Mehta A (2011) Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India. J Clin Microbiol 49: 1588-1590. doi: 10.1128/JCM.00113-11 PMID: 21289142
36. Ali A, Hasan R, Jabeen K, Jabeen N, Qadeer E, et al. (2011) Characterization of Mutations Conferring Extensive Drug Resistance to Mycobacterium tuberculosis Isolates in Pakistan. Antimicrob Agents Chemother 55: 5654-5659. doi: 10.1128/AAC.05101-11 PMID: 21911575
37. Ali A, Hasan Z, Moatter T, Tanveer M, Hasan R (2009) M. tuberculosis Central Asian Strain 1 MDR isolates have more mutations in rpoB and katG genes compared with other genotypes. Scand J Infect Dis 41: 37-44. doi: 10.1080/00365540802570519 PMID: 19012077
38. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, et al. (2011) Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 2032-2041. doi: 10. 1128/AAC.01550-10 PMID: 21300839
39. Casali N, Nikolayevskyy V, Balabanova Y, Ignatyeva O, Kontsevaya I, et al. (2012) Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res 22: 735-745. doi: 10.1101/gr.128678. 111 PMID: 22294518
40. Comas I, Borrell S, Roetzer A, Rose G, Malla B, et al. (2011) Whole-genome sequencing of rifampicinresistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat Genet 44: 106-110. doi: 10.1038/ng.1038 PMID: 22179134
41. de Vos M, Muller B, Borrell S, Black PA, van Helden PD, et al. (2013) Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Agents Chemother 57: 827-832. doi: 10.1128/AAC.01541-12 PMID: 23208709
42. Arjomandzadegan M, Titov LP, Surkova LK, Farnia P, Sheikholeslami F, et al. (2012) Determination of principal genotypic groups among susceptible, MDR and XDR clinical isolates of Mycobacterium tuberculosis in Belarus and Iran. Tuberk Toraks 60: 153-159. PMID: 22779936
43. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 2869-2873. PMID: 16477032
44. Shang S, Harton M, Tamayo MH, Shanley C, Palanisamy GS, et al. (2011) Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosis. Tuberculosis (Edinb) 91: 378-385. doi: 10.1016/j.tube.2011.06.001 PMID: 21737349
45. de Steenwinkel JE, ten Kate MT, de Knegt GJ, Kremer K, Aarnoutse RE, et al. (2012) Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. Emerg Infect Dis 18: 660-663. doi: 10.3201/eid1804.110912 PMID: 22469099
46. Ioerger TR, Feng Y, Chen X, Dobos KM, Victor TC, et al. (2010) The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11: 670. doi: 10.1186/1471-2164-11-670 PMID: 21110864
47. Spies FS, von Groll A, Ribeiro AW, Ramos DF, Ribeiro MO, et al. (2013) Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes. Tuberculosis (Edinb) 93: 150-154. doi: 10.1016/j.tube.2012.11.004 PMID: 23276692
48. Vilcheze C, Wang F, Arai M, Hazbon MH, Colangeli R, et al. (2006) Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med 12: 1027-1029. PMID: 16906155
49. Valvatne H, Syre H, Kross M, Stavrum R, Ti T, et al. (2009) Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. J Antimicrob Chemother 64: 694-701. doi: 10.1093/jac/dkp292 PMID: 19710078
50. Stoffels K, Mathys V, Fauville-Dufaux M, Wintjens R, Bifani P (2012) Systematic analysis of pyrazina-mide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56: 5186-5193. doi: 10.1128/AAC.05385-11 PMID: 22825123
51. Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z (2003) Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52: 790-795. PMID: 14563891
52. Tan Y, Hu Z, Zhang T, Cai X, Kuang H, et al. (2013) Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China. J Clin Microbiol 52: 291-297. doi: 10.1128/JCM.01903-13 PMID: 24131688
53. Sheen P, Lozano K, Gilman RH, Valencia HJ, Loli S, et al. (2013) pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 93: 515-522. doi: 10.1016/j.tube.2013.03.005 PMID: 23867321
54. Sirgel FA, Warren RM, Streicher EM, Victor TC, van Helden PD, et al. (2012) embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis. Chemotherapy 58: 358-363. doi: 10.1159/000343474 PMID: 23171739
55. Srivastava S, Garg A, Ayyagari A, Nyati KK, Dhole TN, et al. (2006) Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis. Curr Microbiol 53: 401-405. PMID: 16972132
56. Liu CH, Li HM, Lu N, Wang Q, Hu YL, et al. (2012) Genomic sequence based scanning for drug resis-tance-associated mutations and evolutionary analysis of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis. J Infect.
57. Chan RC, Hui M, Chan EW, Au TK, Chin ML, et al. (2007) Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 59: 866-873. PMID: 17360809
58. Jnawali HN, Yoo H, Ryoo S, Lee KJ, Kim BJ, et al. (2013) Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea. World J Microbiol Biotechnol.
59. Meier A, Kirschner P, Bange FC, Vogel U, Bottger EC (1994) Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother 38: 228-233. PMID: 8192448
60. Okamoto S, Tamaru A, Nakajima C, Nishimura K, Tanaka Y, et al. (2007) Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol 63: 1096-1106. PMID: 17238915
61. Verma JS, Gupta Y, Nair D, Manzoor N, Rautela RS, et al. (2014) Evaluation of gidB alterations responsible for streptomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 69: 2935-2941. doi: 10.1093/jac/dku273 PMID: 25074855
62. Sirgel FA, Tait M, Warren RM, Streicher EM, Bottger EC, et al. (2011) Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. Microb Drug Resist 18: 193-197. doi: 10.1089/mdr.2011.0063 PMID: 21732736
63. Maus CE, Plikaytis BB, Shinnick TM (2005) Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49: 571-577. PMID: 15673735
64. Sirgel FA, Warren RM, Streicher EM, Victor TC, van Helden PD, et al. (2012) gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis. J Antimicrob Chemother 67: 1088-1093. doi: 10.1093/jac/dks033 PMID: 22357804
65. Yin X, Yu Z (2010) Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J Infect 61: 150-154. doi: 10. 1016/j.jinf.2010.05.001 PMID: 20452372
66. El Garch F, Lismond A, Piddock LJ, Courvalin P, Tulkens PM, et al. (2010) Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. J Antimicrob Chemother 65: 2076-2082. doi: 10.1093/jac/dkq287 PMID: 20709735
67. Wang K, Pei H, Huang B, Zhu X, Zhang J, et al. (2013) The expression of ABC efflux pump, Rv1217c-Rv1218c, and its association with multidrug resistance of Mycobacterium tuberculosis in China. Curr Microbiol 66: 222-226. doi: 10.1007/s00284-012-0215-3 PMID: 23143285
68. Dalla Costa ER, Ribeiro MO, Silva MS, Arnold LS, Rostirolla DC, et al. (2009) Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America. BMC Microbiol 9: 39. doi: 10.1186/1471-2180-9-39 PMID: 19228426
69. Spies FS, von Groll A, Ribeiro AW, Ramos DF, Ribeiro MO, et al. (2012) Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes. Tuberculosis (Edinb) 93: 150-154.